247 related articles for article (PubMed ID: 21422324)
1. Resolution of odontogenic keratocysts of the jaw in basal cell nevus syndrome with GDC-0449.
Goldberg LH; Landau JM; Moody MN; Kazakevich N; Holzer AM; Myers A
Arch Dermatol; 2011 Jul; 147(7):839-41. PubMed ID: 21422324
[TBL] [Abstract][Full Text] [Related]
2. Treatment of multiple unresectable basal cell carcinomas from Gorlin-Goltz syndrome: a case report.
Ojevwe FO; Ojevwe CD; Zacny JP; Dudek AZ; Lin A; Kohlitz P
Anticancer Res; 2015 Mar; 35(3):1777-81. PubMed ID: 25750342
[TBL] [Abstract][Full Text] [Related]
3. Expression of the Sonic Hedgehog receptor "PATCHED" in basal cell carcinomas and odontogenic keratocysts.
Zedan W; Robinson PA; Markham AF; High AS
J Pathol; 2001 Aug; 194(4):473-7. PubMed ID: 11523056
[TBL] [Abstract][Full Text] [Related]
4. Patient with Gorlin syndrome and metastatic basal cell carcinoma refractory to smoothened inhibitors.
Zhu GA; Li AS; Chang AL
JAMA Dermatol; 2014 Aug; 150(8):877-9. PubMed ID: 24898076
[TBL] [Abstract][Full Text] [Related]
5. Odontogenic keratocysts are an important clue for diagnosing basal cell nevus syndrome.
Kaibuchi-Ando K; Takeichi T; Ito Y; Takeuchi S; Yamashita Y; Yamada M; Muro Y; Ogi T; Akiyama M
Nagoya J Med Sci; 2021 May; 83(2):393-396. PubMed ID: 34239189
[TBL] [Abstract][Full Text] [Related]
6. Hedgehog Pathway Inhibition for Locally Advanced Periocular Basal Cell Carcinoma and Basal Cell Nevus Syndrome.
Ozgur OK; Yin V; Chou E; Ball S; Kies M; William WN; Migden M; Thuro BA; Esmaeli B
Am J Ophthalmol; 2015 Aug; 160(2):220-227.e2. PubMed ID: 25935097
[TBL] [Abstract][Full Text] [Related]
7. Oral hedgehog-pathway inhibitors for basal-cell carcinoma.
Lear JT
N Engl J Med; 2012 Jun; 366(23):2225-6. PubMed ID: 22670909
[No Abstract] [Full Text] [Related]
8. Targeting the hedgehog pathway to treat basal cell carcinoma.
Geeraert P; Williams JS; Brownell I
J Drugs Dermatol; 2013 May; 12(5):519-23. PubMed ID: 23652945
[TBL] [Abstract][Full Text] [Related]
9. Expanded access study of patients with advanced basal cell carcinoma treated with the Hedgehog pathway inhibitor, vismodegib.
Chang AL; Solomon JA; Hainsworth JD; Goldberg L; McKenna E; Day BM; Chen DM; Weiss GJ
J Am Acad Dermatol; 2014 Jan; 70(1):60-9. PubMed ID: 24189279
[TBL] [Abstract][Full Text] [Related]
10. Vismodegib in advanced basal-cell carcinoma.
Henkin RI
N Engl J Med; 2012 Sep; 367(10):970; author reply 970-1. PubMed ID: 22931271
[No Abstract] [Full Text] [Related]
11. Gorlin syndrome or basal cell nevus syndrome (BCNS): A case report.
Shivaswamy KN; Sumathy TK; Shyamprasad AL; Ranganathan C
Dermatol Online J; 2010 Sep; 16(9):6. PubMed ID: 20875327
[TBL] [Abstract][Full Text] [Related]
12. Vismodegib for the treatment of basal cell carcinoma: results and implications of the ERIVANCE BCC trial.
Dessinioti C; Plaka M; Stratigos AJ
Future Oncol; 2014 May; 10(6):927-36. PubMed ID: 24941979
[TBL] [Abstract][Full Text] [Related]
13. Emergence of chemoresistance in a metastatic basal cell carcinoma patient after complete response to hedgehog pathway inhibitor vismodegib (GDC-0449).
Meani RE; Lim SW; Chang AL; Kelly JW
Australas J Dermatol; 2014 Aug; 55(3):218-21. PubMed ID: 25117162
[TBL] [Abstract][Full Text] [Related]
14. "PTCH"-ing it together: a basal cell nevus syndrome review.
Lam C; Ou JC; Billingsley EM
Dermatol Surg; 2013 Nov; 39(11):1557-72. PubMed ID: 23725561
[TBL] [Abstract][Full Text] [Related]
15. Basal cell carcinoma rebound after cessation of vismodegib in a nevoid basal cell carcinoma syndrome patient.
Wolfe CM; Green WH; Cognetta AB; Hatfield HK
Dermatol Surg; 2012 Nov; 38(11):1863-6. PubMed ID: 22805146
[No Abstract] [Full Text] [Related]
16. Invasive Basal Cell Carcinoma of the Skin Treated Successfully with Vismodegib: A Case Report.
Awad R; Andrade JCB; Mousa H; Mahmoud F
Perm J; 2018; 22():17-181. PubMed ID: 30005721
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of vismodegib in patients with basal cell carcinoma nevus syndrome: pooled analysis of two trials.
Chang AL; Arron ST; Migden MR; Solomon JA; Yoo S; Day BM; McKenna EF; Sekulic A
Orphanet J Rare Dis; 2016 Sep; 11(1):120. PubMed ID: 27581207
[TBL] [Abstract][Full Text] [Related]
18. [Skeletal and dermatological manifestations of the nevoid Basal cell carcinoma syndrome (Gorlin-Goltz syndrome). Results of 8 patients in 12 years].
Rupprecht M; Mensing CH; Barvencik F; Ittrich H; Heiland M; Rueger JM; Amling M; Pogoda P
Rofo; 2007 Jun; 179(6):618-26. PubMed ID: 17492539
[TBL] [Abstract][Full Text] [Related]
19. Odontogenic keratocysts: review of the literature and report of a case.
Blanchard SB
J Periodontol; 1997 Mar; 68(3):306-11. PubMed ID: 9100207
[TBL] [Abstract][Full Text] [Related]
20. Familial odontogenic keratocysts. Report of 3 cases and review of Japanese dental literature.
Kamiya Y; Narita H; Yamamoto T; Kameyama Y; Maeda H; Nakane S
Int J Oral Surg; 1985 Feb; 14(1):73-80. PubMed ID: 2580807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
